1. Home
  2. RRC vs ROIV Comparison

RRC vs ROIV Comparison

Compare RRC & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Range Resources Corporation

RRC

Range Resources Corporation

HOLD

Current Price

$36.43

Market Cap

10.1B

Sector

Energy

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$31.14

Market Cap

21.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRC
ROIV
Founded
1976
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
21.0B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
RRC
ROIV
Price
$36.43
$31.14
Analyst Decision
Hold
Strong Buy
Analyst Count
18
9
Target Price
$43.67
$28.94
AVG Volume (30 Days)
2.6M
5.6M
Earning Date
04-21-2026
05-28-2026
Dividend Yield
0.92%
N/A
EPS Growth
151.38
N/A
EPS
1.44
N/A
Revenue
$3,115,515,000.00
$8,260,000.00
Revenue This Year
$15.60
N/A
Revenue Next Year
$9.73
$744.61
P/E Ratio
$25.39
N/A
Revenue Growth
28.90
N/A
52 Week Low
$32.60
$10.71
52 Week High
$48.31
$32.79

Technical Indicators

Market Signals
Indicator
RRC
ROIV
Relative Strength Index (RSI) 31.37 60.76
Support Level $34.27 $27.44
Resistance Level $36.61 $32.79
Average True Range (ATR) 1.00 0.93
MACD -0.22 0.20
Stochastic Oscillator 6.44 75.99

Price Performance

Historical Comparison
RRC
ROIV

About RRC Range Resources Corporation

Range Resources is an exploration and production firm whose operations represent a pure play in the Marcellus shale, located in the Appalachian region of Southwest Pennsylvania. The company went public as Lomak Petroleum in 1980 and later reorganized as Range Resources in 1998. After an expensive 10-year venture with a multi-basin strategy, Range Resources found its identity as an Appalachian natural gas producer, offloading its Permian assets in 2013. Range quickly became a leading US gas producer after its merger with Memorial Resource Development in 2016. Following the merger, Range saw its operational unit costs rise to an uncompetitive level and subsequently sold the assets in 2020 to return to its roots as an Appalachian producer.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: